These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6019862)

  • 1. [So-called cutaneous porphyria of the adult in a child revealed by viral hepatitis. Treatment with adenosine-5'-monophosphoric acid].
    Gajdos A; Plainfossé B; Seringe P
    Presse Med (1893); 1967 Mar; 75(11):545-7. PubMed ID: 6019862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute intermittent porphyria accompanied by galactorrhea, treated with adenosine-5-monophosphoric acid].
    Kvĕtenský J; Zaorálek A; Harínová E
    Vnitr Lek; 1966 Jun; 12(6):601-6. PubMed ID: 5950417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of so-called adult cutaneous porphyria].
    Gjdos A
    Presse Med (1893); 1968 Jan; 76(5):207-8. PubMed ID: 5638172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of adenosine-5-monophosphoric acid and inosine on experimental porphyria induced in rats by griseofulvin].
    Gajdos A; Gajdos-Török M
    Nouv Rev Fr Hematol; 1965; 5(4):591-9. PubMed ID: 4221222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute intermittent prophyria using adenosine monophosphoric acid].
    Wiontzek H
    Med Klin; 1969 Jul; 64(27):1238-40. PubMed ID: 5799781
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute intermittent porphyria. Report of a case treated with adenosine 5 phosphoric acid.
    Oaks WW; Schultz J; Fleischmajer R
    Dermatologica; 1969; 138(1):10-8. PubMed ID: 5764297
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute intermittent porphyria with adenosine-5-monophosphate: a long-term double-blind study.
    Wetterberg L
    J Clin Pharmacol J New Drugs; 1970; 10(3):199-202. PubMed ID: 5266632
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical picture and adenyl therapy of acute intermittent porphyria].
    Fedor I; Tóth J; Földváry G
    Orv Hetil; 1971 Mar; 112(10):552-3. PubMed ID: 5579317
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new variety of porphyria, mixed or variegate hereditary coproporphyria].
    Gajdos A; Weil J; Gajdos-Török M; Coupry A
    Rev Fr Etud Clin Biol; 1969 Mar; 14(3):279-82. PubMed ID: 5790137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Catamnestic studies in porphyria cutanea tarda with special reference to therapy].
    Barth J; Petter O
    Z Gesamte Inn Med; 1971 Jan; 26(2):66-74. PubMed ID: 5560767
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of adenosine-5-monophosphoric acid or inosine on porphyria caused by griseofulvin in rats.
    Gajdos A; Gajdos-Török M
    Nature; 1965 Apr; 206(981):297-8. PubMed ID: 5836322
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial ischemic syndrome associated with plasma cryoprecipitation and cutaneous porphyria in adults].
    Gorin N; Jacotot B; Buxtorf JC; Beaumont JL
    Presse Med (1893); 1970 May; 78(24):1111-2. PubMed ID: 5422819
    [No Abstract]   [Full Text] [Related]  

  • 13. [ESSENTIAL PORPHYRIA IN CHILDREN. APROPOS OF A CASE OF GUENTHER'S DISEASE TREATED WITH ADENOSINE-5'-MONOPHOSPHORIC ACID].
    LAUSEKER C; HARTLEYB H; GAJDOS A; GAJDOS-TOROK M; FISCHER D
    Arch Fr Pediatr; 1965 Feb; 22():137-65. PubMed ID: 14335774
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of congenital porphyria treated by adenosine-5-monophosphoric acid].
    GAJDOS A; GAJDOS-TOROK M; HARTLEYB H; LAUSECKER C
    Presse Med (1893); 1963 May; 71():1294-6. PubMed ID: 13946172
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and experimental trial of adenosine-5-monophosphoric acid in porphyria.
    GAJDOS A; GAJDOS-TOROK M
    Panminerva Med; 1962; 4():332-40. PubMed ID: 13946166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and therapeutic remarks apropos of a case of acute porphyria. Favorable action of adenosine monophosphoric acid].
    LEVRAT M; TISSOT A; MOULINIER B; TETE R
    Lyon Med; 1963 Jul; 210():37-47. PubMed ID: 13930219
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental porphyria induced with 2-allyloxy-3-methylbenzamide. V. Interference of inosine and adenosine-5-monophosphoric acid in the alteration of porphyrin metabolism].
    Massaro AL; Mazza U; Battistini V; Bianco G; Prato V
    Boll Soc Ital Biol Sper; 1967 Apr; 43(7):357-9. PubMed ID: 6052520
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of adenosine-5-monophosphoric acid on porphyria induced in the white rat ith allylisopropylacetylcarbamide].
    GAJDOS A; GAJDOS-TOR OK M
    C R Seances Soc Biol Fil; 1962; 156():1565-6. PubMed ID: 13946168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience in the treatment of acute migrating porphyria].
    Smirnov IuK; Idel'son LI; Krasikova LI
    Klin Med (Mosk); 1967 Oct; 45(10):129-33. PubMed ID: 5610143
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL PORPHYRIA INDUCED IN THE WHITE RAT BY GRISEOFULVIN. FAVORABLE EFFECT OF TREATMENT BY ADENOSINE-5'-MONOPHOSPHORIC ACID].
    GAJDOS A; GAJDOS-TOEROEK M
    C R Seances Soc Biol Fil; 1964; 158():1316-9. PubMed ID: 14210562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.